Happell 2018.
Study name | Improving the cardio‐metabolic health of people with psychosis |
Methods | Setting: community‐based mental health service in a large metropolitan city in Australia Allocation: randomised controlled trial; block randomisation stratified by age and gender Masking: participants and outcome assessors will be masked until after baseline assessment. Team members conducting data analysis will not be involved in data collection. Treatment allocations will be masked until after data analysis. |
Participants | Diagnosis: diagnosed with a DSM‐V psychotic disorder n = 160 Age: 18 to 65 |
Interventions | Physical health nurse consultant (PHNC): will co‐ordinate physical health care including supported referral to appropriate programmes/services. The PHNC will manage risk using the positive cardiometabolic health treatment framework and will work in collaboration with consumers on self‐identified needs, goals and health priorities. Control: usual care Comparison: PHNC + usual care vs usual care |
Outcomes | Primary outcomes:
|
Starting date | Late 2018 |
Contact information | brenda.happell@canberra.edu.au |
Notes | Not described by the triallists as 'collaborative care'. Emailed PI in October 2020; trial due to end December 2020, but in process of negotiating an extension until December 2021. |